By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.
I agree
Search Trends
SITEMAP
Copyright © 2024 CGTN. 京ICP备20000184号
Disinformation report hotline: 010-85061466
SITEMAP
Copyright © 2024 CGTN. 京ICP备20000184号
Disinformation report hotline: 010-85061466
Kobayashi Pharmaceutical, a Japanese drugmaker, is facing challenges in restoring public trust after failing to promptly disclose potential health hazards due to economic considerations, according to a local medical professional. The Osaka-based pharmaceutical giant has initiated recalls of several products. As of Friday, the products have been associated with five deaths and over 100 hospitalizations, with nearly 700 others seeking medical advice or planning to do so.